ACG: Physical Activity Reduces Risk of Esophageal Cancer

Share this content:
ACG: Physical Activity Linked to Lower Risk of Esophageal Cancer
ACG: Physical Activity Linked to Lower Risk of Esophageal Cancer

(HealthDay News) -- Physical activity is associated with a reduced risk of esophageal cancer (EC), according to a review and meta-analysis presented at the annual meeting of the American College of Gastroenterology, held from Oct. 11 to 16 in San Diego.

Siddharth Singh, M.B.B.S., from the Mayo Clinic in Rochester, Minn., and colleagues reviewed the literature and conducted a meta-analysis of eight observational studies that examined the correlation between recreational and/or occupational physical activity and the risk of EC.

The researchers found that, compared with the least physically active people, the most physically active people had a significantly lower risk of EC (five studies: odds ratio, 0.81), with low heterogeneity among the studies (I² = 33 percent). Physical activity correlated with lower risk of esophageal adenocarcinoma (four studies: odds ratio [OR], 0.68; 95% confidence interval [CI], 0.55 to 0.85), while the risk of esophageal squamous cell cancer was not significantly reduced (two studies: OR, 0.46; 95% CI, 0.08 to 2.73). Recreational, but not occupational, physical activity correlated with a reduction in the risk of EC (three studies: OR, 0.83; 95% CI, 0.69 to 1.00).

"By decreasing visceral fat, lowering the level of carcinogenic adipokines, improving insulin sensitivity, and decreasing chronic inflammation, physical activity can potentially decrease risk of esophageal cancer," Singh said in a statement.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs